FLOW CYTOMETRY MARKET ANALYSIS

Flow cytometry instruments require a significant capital investment, ranging anywhere from US$ 100,000 to over US$ 500,000 depending on the complexity of the system. Similarly, reagents, antibodies and other consumables used in flow cytometry experiments also have high recurring costs. Setting up a core flow cytometry facility mandates not just the instrument but specialized infrastructure like vibration isolation tables, electricity and gas backups, and trained staff for operation and maintenance, which adds to the overhead costs substantially.

Market Opportunities – Combined Technologies

Combined technologies have the potential to vastly expand applications and use cases for flow cytometry. By integrating analytical capabilities from multiple disciplines, combined approaches allow researchers to gain novel insights from cells and biologics. For example, the integration of cell sorting with genomics offers an unmatched view of cell states and phenotypes. Researchers can isolate specific cell populations based on surface marker expression and other characteristics, then analyze gene expression profiles or genome sequences. This powerful combination reveals how cellular characteristics correlate with genomic patterns on a single-cell level. Technologies that pair flow cytometry with mass spectrometry also show promise, identifying proteins, lipids, and other molecules expressed within sorted populations.